Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicola Alesi, M.D.

Concepts (66)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Monomeric GTP-Binding Proteins220222041.600 Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors120213240.710 Why?
Lysosomes220219460.690 Why?
Tuberous Sclerosis4201810150.370 Why?
Phosphoserine120212230.210 Why?
Tumor Suppressor Proteins3202129070.190 Why?
Mice, Inbred NOD2202119280.180 Why?
Class III Phosphatidylinositol 3-Kinases12018210.180 Why?
Angiomyolipoma220181910.170 Why?
Pinocytosis12018810.170 Why?
Mice, SCID2202128450.170 Why?
Lymphangioleiomyomatosis220182400.160 Why?
Protein Transport1202120660.140 Why?
HeLa Cells1202132430.130 Why?
Receptors, LDL120175430.130 Why?
Kidney Neoplasms3202140460.130 Why?
Cell Nucleus1202130180.110 Why?
HEK293 Cells1202143290.110 Why?
Multiprotein Complexes1201711720.100 Why?
Phosphorylation1202187430.090 Why?
Proto-Oncogene Proteins1202146970.080 Why?
Cholesterol1201728940.080 Why?
Cell Proliferation22021108020.080 Why?
TOR Serine-Threonine Kinases1201721170.080 Why?
Transcription, Genetic1202179520.080 Why?
Carcinoma, Renal Cell1202129680.070 Why?
Membrane Glycoproteins1201738640.070 Why?
Methotrexate1201117320.060 Why?
Mitochondria1201736410.060 Why?
Carrier Proteins1201751350.060 Why?
Gene Expression Regulation12021124330.060 Why?
Immunotherapy1201841370.060 Why?
Mice42021811260.050 Why?
Amiloride120181260.040 Why?
Dextrans120186170.040 Why?
Animals420211708900.040 Why?
Glutathione120176160.030 Why?
Loss of Heterozygosity120166830.030 Why?
Cell Line22018166930.030 Why?
Fluorescent Antibody Technique1201726690.030 Why?
Folic Acid Antagonists12011820.030 Why?
Down-Regulation1201830940.020 Why?
Autophagy1201813470.020 Why?
Up-Regulation1201843560.020 Why?
Germ-Line Mutation1201617320.020 Why?
Drug Therapy, Combination1201865420.020 Why?
Antimetabolites, Antineoplastic120116510.020 Why?
Intracellular Signaling Peptides and Proteins1201730100.020 Why?
Pharmacogenetics120116990.020 Why?
Tumor Microenvironment1201831000.020 Why?
Homeostasis1201733440.020 Why?
Urinary Bladder Neoplasms1201821000.020 Why?
Drug Resistance1201116130.020 Why?
Female220213779090.020 Why?
High-Throughput Nucleotide Sequencing1201636980.020 Why?
Immunohistochemistry12017117770.010 Why?
Humans420217172370.010 Why?
Mutation22018294910.010 Why?
Protein Kinase Inhibitors1201854950.010 Why?
Mice, Knockout12017152580.010 Why?
T-Lymphocytes12018103760.010 Why?
Polymorphism, Genetic1201143520.010 Why?
Mice, Inbred C57BL12018229290.010 Why?
Disease Models, Animal12017183520.010 Why?
Male220183513800.010 Why?
Adult120162124510.000 Why?
Alesi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.